Aimmune Therapeutics Inc. (AIMT) Gained 5.33% or 1.47 To Price $29.07 On Wednesday


Aimmune Therapeutics Inc. (AIMT) gained 5.33% or 1.47 to $29.07. It is nearly 680320 shares traded, which is 213.52% compare to the average total volume 318621. The market cap of AIMT is $1.70 billion. The year to date change is -20.86%. The 52 week price range is from $22.85 to $42.0. Price of AIMT have changed 2.72% during last week. It have changed -2.61% over last month, -10.85% over last 3 months, -15.42% over last 6 months and 19.12% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AIMT is 28.38. It is -2.37% below current price. The 200-day Moving Averages for AIMT is 32.19. It is 10.73% above current price. The 52-week High is 42.0. It is 44.48% from the current price. The 52-week Low is 22.85. It is -21.40% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AIMT is 16.72 on 2018-08-15. Short % to float is 9.64%. There are some statistics of AIMT. It is has market cap $1.70 billion. The share outstanding is 58.48 million. The average volume is 318621. The percent of top 15 Institution holding is 69.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AIMT is -66.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AIMT is -60.04%.


Tags:

Share this post